N

Active Director Director DIN 09518878
DIN 09518878 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Nadarsha

Data last updated:

Nadarsha is a Director at Rivolga Private Limited (since 2022). The company operates in Pharma. Rivolga Private Limited reported revenue of ₹2.52 Cr (FY 2025).

DIN 09518878
Primary Designation Director
Industry Pharma
First Appointment 25 Feb 2022
Oldest Company Age 4 yrs
Largest company Rivolga Private Limited · ₹2.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rivolga Private Limited U24299KL2022PTC073618
Director25 Feb 20222022₹2.52 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Rivolga Private Limited
Premium access

Shareholding and investment profile for Nadarsha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nadarsha

Nadarsha currently holds 1 directorship: Rivolga Private Limited (Director, since 25 Feb 2022, revenue ₹2.52 Cr (FY 2025)).

Nadarsha was first appointed on 25 Feb 2022 as Director at Rivolga Private Limited.

The current boards of Nadarsha's companies include Afnaz Ashraf (Rivolga Private Limited), Elampallil Sugunan Suneesh (Rivolga Private Limited), Jijo Antony (Rivolga Private Limited), Kunjumon Vineesh (Rivolga Private Limited), Radha Krishnan Praveen (Rivolga Private Limited), Sreevas S Tholoor (Rivolga Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available